Ocugen (OCGN) EBT Margin (2014 - 2026)
Ocugen's (OCGN) quarterly EBT Margin came in at 2339.14% in Q1 2026, down 129538.0% YoY from N/an in Q1 2025, and down 125.03% on a QoQ basis from 9344.04% in Q4 2025.
Powered by 
Analysis
Ocugen (OCGN) EBT Margin (2014 - 2026) Analysis & Trends
Ocugen (OCGN) has 7 years of EBT Margin data on file, last reported at 2339.14% in Q1 2026.
- Quarterly EBT Margin fell 129538.0% year-over-year to 2339.14% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2077.65% (down 67639.0% YoY) and the FY2025 annual result came in at 4487.63%, down 21949.0% from the prior year.
- EBT Margin eased to 2339.14% in Q1 2026, from 9344.04% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 9344.04% in Q4 2025 to a low of 8796.17% in Q4 2023.
- A 5-year average of 2443.38% and a median of 1839.18% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2023 — EBT Margin slumped 630026 bps — and 2025, when it surged 1116878 bps.
- Tracing OCGN's EBT Margin over 5 years: stood at 2495.9% in 2022, then slumped by 252 bps to 8796.17% in 2023, then soared by 79 bps to 1824.74% in 2024, then soared by 612 bps to 9344.04% in 2025, then plunged by 125 bps to 2339.14% in 2026.
- The last three EBT Margin figures came in at 2339.14% (Q1 2026), 9344.04% (Q4 2025), and 1069.18% (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 35.78% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -528.97% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 18.33% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 13.77% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -2.67% |
| 10 | Ocugen | 458.91 Mn | 358.81 Mn | - | -1,379.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,379.03% |
| Mar 31, 2026 | -1,241.16% |
| Dec 31, 2025 | 9,432.64% |
| Sep 30, 2025 | -1,069.18% |
| Jun 30, 2025 | -1,081.79% |
| Mar 31, 2025 | -1,040.85% |
| Dec 31, 2024 | -1,830.37% |
| Sep 30, 2024 | -1,141.81% |
| Jun 30, 2024 | -1,338.83% |
| Mar 31, 2024 | -1,174.95% |
| Dec 31, 2023 | -817.96% |
| Sep 30, 2023 | -336.06% |
| Jun 30, 2023 | -4,853.61% |
| Mar 31, 2023 | -4,071.11% |
| Dec 31, 2022 | -2,495.90% |
| Sep 30, 2022 | -4,704.29% |
| Jun 30, 2022 | -3,355.52% |
| Mar 31, 2022 | -3,806.00% |
| Jun 30, 2020 | -8,404.65% |
| Sep 30, 2014 | -1.50% |